Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Top Cited Papers
- 1 May 2018
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 19 (5) , 705-714
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Pediatric PharmacokineticsPediatric Clinics of North America, 2012
- The PedsQL™ Infant Scales: feasibility, internal consistency reliability, and validity in healthy and ill infantsQuality of Life Research, 2010
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupJournal of Clinical Oncology, 2010
- Infantile Fibrosarcoma: Management Based on the European ExperienceJournal of Clinical Oncology, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Identification of paediatric cancer patients with poor quality of lifeBritish Journal of Cancer, 2008
- Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six DesignJournal of Clinical Oncology, 2008
- Congenital-Infantile FibrosarcomaAmerican Journal of Clinical Pathology, 2001
- Q.U.E.S.TOrthopaedic Nursing, 1987
- A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequencesNature, 1986